Progyny (PGNY) revenue breakdown
By product, Fertility benefit services revenue is the largest at 64% of fiscal 2025 revenue; Pharmacy benefit services revenue grew fastest, 88% a year over 7 years.
Revenue by product
Fiscal years, as Progyny reports them in its 10-K filings; fiscal 2025 total $1.3B.
| Products | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|
| Fertility benefit services revenue | $100M | $190M | $254M | $356M | $510M | $676M | $730M | $831M | 64% |
| Pharmacy benefit services revenue | $6M | $40M | $91M | $145M | $277M | $412M | $438M | $458M | 36% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PGNY.
Open PGNY in InvestinglyQuestions
Where does Progyny make its money?
In fiscal 2025, by product: Fertility benefit services revenue $831M, Pharmacy benefit services revenue $458M.
From Progyny's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.